Pharma Supplier Hub

Benchling is a cloud-based, biology-first R&D platform that unifies ELN, structured scientific data, automation, and embedded AI for biotech and biopharma teams. It supports discovery, in vivo, biologics, and bioprocess development on an open, integrable platform backed by services, training, and a global community, helping organizations digitize labs and accelerate milestones.

CloudLIMS is a configurable, cloud-based LIMS delivered as SaaS for biobanks, clinical, research, cannabis, environmental, and analytical testing labs. It supports sample and subject management, test and inventory workflows, client portals, QA/QC, instrument integration, and reporting to help laboratories automate operations, support compliance such as ISO 17025, and stay audit-ready without on-premise IT infrastructure.

Codexis is a specialist RNA manufacturer and enzyme engineering partner offering ECO Synthesis® and CodeEvolver® platforms for greener, scalable therapeutic manufacturing. The company provides RNA manufacturing, pharma biocatalysis and molecular biology enzyme solutions, along with RNA ligation and enzyme evolution services, to help pharma and biotech teams improve yield, quality and sustainability from development through scale‑up.

Confience provides myLIMS, a cloud-based LIMS for regulated laboratory operations with sample tracking, compliance, traceability, and automation. The platform is positioned for pharma-adjacent, R&D, and quality-control lab environments that need configurable workflows and instrument integration.

BioPharmaSpec is a global CRO specializing in structural, physicochemical and biophysical characterization of biopharmaceuticals using advanced mass spectrometry and chromatographic techniques. It supports discovery and preclinical development of monoclonal antibodies, ADCs, gene therapies, oligonucleotides and other biologics with ICH Q6B-aligned analytical services and impurity profiling from laboratories in the UK, EU and US.

Countable Labs is a private genomics technology company that develops the Countable PCR platform for true single-molecule DNA quantification. Using ~30 million compartments per reaction, Countable PCR delivers 0.004% MAF sensitivity, <1% CV precision, and 6-log dynamic range for oncology, rare event detection, NIPT, infectious disease, and cell and gene therapy workflows.

Creative Peptides is a New York–based peptide CDMO and supplier providing custom peptide synthesis, modification, conjugation, labeling, analysis, and GMP manufacturing. It offers bioactive peptide APIs and research-grade catalog products to support drug discovery, clinical development, and cosmetic innovation under strict cGMP quality systems.

Cryologyx is a University of Warwick spin-out biotech developing next-generation cryoprotectants and cryopreserved, assay-ready cells for medicines discovery, diagnostics, and cell-based therapies. Its patented molecular shield technology aims to improve cell and blood cell quality after thawing, supporting more reliable drug discovery workflows and future applications in transfusion and advanced therapies.

Cyagen Biosciences is a global CRO specializing in genetically engineered rodent models, custom cell lines, viral packaging and integrated preclinical studies for drug discovery and translational research. With large KO/cKO and humanized mouse libraries, AAALAC-accredited SPF facilities, and platforms such as HUGO-GT™ and HUGO-Ab™, Cyagen supports pharma, biotech and academic customers from target validation through IND-enabling preclinical validation.

Helus Pharma (Cybin Inc. d/b/a Helus Pharma) is a clinical-stage neuropsychiatry company developing next-generation serotonergic agonist therapies and proprietary delivery systems for mental health disorders. With two lead programs, a broad patent portfolio, and experienced neuropsychiatry and regulatory leadership, Helus focuses on durable, clinically practical treatments for conditions such as major depressive disorder and generalized anxiety disorder.

Cyprotex ADME-Tox Solutions, part of Evotec, provides in vitro and in silico ADME, PK and predictive toxicology services across discovery and preclinical development. Its unique platforms (eCiphr Cardio, eCiphr Neuro, CellCiphr Premier) and modeling tools support human-relevant predictions of exposure, efficacy and safety for pharmaceutical, biotech and chemical clients.

Cytiva is a global life sciences company providing end-to-end technologies, consumables, and services that support biopharma from discovery through commercial manufacturing. As part of Danaher, it offers leading brands such as ÄKTA, Amersham, HyClone, MabSelect, and Whatman, serving pharma, biotech, CDMOs, and academia with integrated bioprocessing and analytical solutions.

DEBRA Research is the global, non-profit research arm of DEBRA Austria dedicated to translational research and clinical development of therapies for Epidermolysis Bullosa (EB). It funds and co-develops EB treatment programs, invests in biotech partners, and builds specialized clinical trial infrastructure to move promising EB therapies from lab to patients.

BioEcho Life Sciences (DNA & RNA Extraction Solutions) provides EchoLUTION single‑step DNA/RNA purification kits and EchoCLEAN cleanup solutions for diagnostics, biopharma R&D, agriculture and academic research. Their phenol‑ and chloroform‑free, high‑throughput formats deliver inhibitor‑free nucleic acids for qPCR, NGS and other genomic applications, from cell culture and tissue to FFPE, viral and plant samples.

Artios Pharma is a clinical-stage biotechnology company focused on DNA Damage Response (DDR)-based cancer therapeutics, including the ATR inhibitor alnodesertib and the Polθ inhibitor ART6043. Supported by its proprietary DcoDeR platform and a preclinical DDRi-ADC portfolio, Artios targets replication stress and DDR defects in solid tumors to deliver first- and best-in-class oncology treatments.

Dassault Systèmes is a global innovation and software company providing the 3DEXPERIENCE platform, virtual twin technology and industrial AI to life sciences and healthcare organizations. Its pharmaceutical and biotech solutions enable end‑to‑end digital transformation from R&D to manufacturing, embedding compliance, quality and traceability while accelerating data‑driven drug development and sustainable product innovation.

Lifebit is a federated data intelligence platform that pioneers Trusted Research Environments for life sciences and biomedical data. It allows pharma, governments and research organizations to analyze sensitive, population-scale health and genomic data in-place, across borders and infrastructures, with strong privacy, security and compliance. The platform accelerates cancer and rare disease discovery, target validation and translational insights from large biobank and clinico-genomic datasets.

DeSci Labs is a Swiss software R&D company building AI-powered, decentralized infrastructure for open science. Its products—SciWeave, DeSci Publish and Reviewer Finder—help researchers, journals and funders accelerate literature review, share versioned manuscripts, data and code with DOIs, and automate reviewer matching and novelty assessment on an open, peer‑to‑peer network.

DeciBio is a private, boutique strategy consulting and market intelligence firm focused on precision medicine and life sciences. It provides diagnostics, pharma, biotech, and research tools companies with biomarker and diagnostics strategy, market research, pricing, go-to-market, and data analytics services to support R&D and commercialization decisions across the precision medicine ecosystem.

10x Genomics is a public biotechnology company that delivers single cell, spatial, and in situ omics platforms used widely in oncology, immunology, neuroscience, and drug development. Its Chromium, Atera, Xenium, and Visium platforms enable high‑resolution characterization of tissues, tumors, and immune responses, supporting target discovery, biomarker development, and AI‑driven R&D across pharma and translational research.

DiaCarta is a precision molecular diagnostics company specializing in oncology and infectious disease testing using proprietary XNA and isobDNA™ technologies. It offers liquid biopsy-based cancer assays, NGS panels, bladder and colorectal cancer tests, OTC at‑home screening, and FDA‑EUA mpox PCR tests, backed by an ISO 13485 GMP facility and a CAP-accredited CLIA lab in California with global reach.

Diasorin is a global diagnostics specialist in immunodiagnostics, molecular diagnostics and licensed technologies, offering LIAISON® immunoassay systems, Simplexa™ and LIAISON NES® molecular tests, and Luminex xMAP® multiplex platforms. Its portfolio spans infectious disease, respiratory, GI, TB and hepatitis testing plus custom assay development, serving clinical labs, hospital networks and life science researchers.

Dolomite Product Line is a discontinued microfluidics line now treated as legacy end-of-support by Unchained Labs. Buyers should verify service status, spare-part availability, and documentation access before relying on it for ongoing lab operations.

Dovendi is a Dutch broker and manager of aftermarket domain names, including life-science-related domains like innosign.nl. It helps buyers and sellers negotiate, transfer, and manage registered domains and offers guidance on domain pricing and acquisition. Pharma and R&D teams would work with Dovendi when acquiring strategic digital assets, not when sourcing lab products or scientific services.